These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 16000605
1. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer. Scagliotti GV. Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605 [Abstract] [Full Text] [Related]
2. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer. Hotta K, Matsuo K, Kiura K, Ueoka H, Tanimoto M. Curr Opin Oncol; 2006 Mar 01; 18(2):144-50. PubMed ID: 16462183 [Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial. Dunant A, Pignon JP, Le Chevalier T. Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606 [Abstract] [Full Text] [Related]
4. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Berghmans T, Paesmans M, Meert AP, Mascaux C, Lothaire P, Lafitte JJ, Sculier JP. Lung Cancer; 2005 Jul 01; 49(1):13-23. PubMed ID: 15949586 [Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer. Erman M, Moretti L, Soria JC, Le Chevalier T, Van Houtte P. Semin Radiat Oncol; 2004 Oct 01; 14(4):315-21. PubMed ID: 15558506 [Abstract] [Full Text] [Related]
6. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease. Wakelee H, Dubey S, Gandara D. Oncologist; 2007 Mar 01; 12(3):331-7. PubMed ID: 17405898 [Abstract] [Full Text] [Related]
7. The current status of adjuvant chemotherapy for resected non-small cell lung cancer. Socinski MA. Semin Oncol; 1999 Oct 01; 26(5 Suppl 15):27-33. PubMed ID: 10566608 [Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy in resected non-small cell lung cancer. Cangiano R. Rays; 2004 Oct 01; 29(4):435-7. PubMed ID: 15852732 [Abstract] [Full Text] [Related]
9. The future of adjuvant chemotherapy for resected non-small cell lung cancer. Vansteenkiste JF, Schildermans RH. Expert Rev Anticancer Ther; 2005 Feb 01; 5(1):165-75. PubMed ID: 15757448 [Abstract] [Full Text] [Related]
11. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association. Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766 [Abstract] [Full Text] [Related]
12. The role of adjuvant chemotherapy for non-small cell lung cancer. Gurubhagavatula S, Lynch TJ. Semin Respir Crit Care Med; 2005 Jun 01; 26(3):298-303. PubMed ID: 16052431 [Abstract] [Full Text] [Related]
13. Adjuvant chemotherapy in non-small cell lung cancer. Le Chevalier T. Semin Oncol; 1998 Aug 01; 25(4 Suppl 9):62-5. PubMed ID: 9728587 [Abstract] [Full Text] [Related]
14. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all? Geiger S, Schlemmer M, Heinemann V, Stemmler HJ. Anticancer Drugs; 2010 Oct 01; 21(9):799-804. PubMed ID: 20679887 [Abstract] [Full Text] [Related]
15. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. Arriagada R, Dunant A, Pignon JP, Bergman B, Chabowski M, Grunenwald D, Kozlowski M, Le Péchoux C, Pirker R, Pinel MI, Tarayre M, Le Chevalier T. J Clin Oncol; 2010 Jan 01; 28(1):35-42. PubMed ID: 19933916 [Abstract] [Full Text] [Related]
16. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer. Johnson BE, Rabin MS. Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607 [Abstract] [Full Text] [Related]
17. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Brambilla E. J Clin Oncol; 2007 Jul 01; 25(19):2735-40. PubMed ID: 17602078 [Abstract] [Full Text] [Related]
18. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Cancer Care Ontario, American Society of Clinical Oncology. J Clin Oncol; 2007 Dec 01; 25(34):5506-18. PubMed ID: 17954710 [Abstract] [Full Text] [Related]
19. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?]. Baumann M. Strahlenther Onkol; 2001 Apr 01; 177(4):220-1. PubMed ID: 11370558 [No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. Pisters KM, Le Chevalier T. J Clin Oncol; 2005 May 10; 23(14):3270-8. PubMed ID: 15886314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]